Clinical Trial Update: Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating proactive therapeutic drug monitoring of infliximab in children with inflammatory bowel diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: IRCCS Burlo Garofolo | Conditions: Inflammatory Bowel Diseases | Phase 4 | Status: UNKNOWN